4.5 Article

Serum Mature BDNF Level Is Associated with Remission Following ECT in Treatment-Resistant Depression

Related references

Note: Only part of the references are listed.
Article Neurosciences

Using routine MRI data of depressed patients to predict individual responses to electroconvulsive therapy

Matti Gaertner et al.

Summary: ECT is a highly effective treatment for severe and treatment resistant major depression, with 60-80% of patients responding to it. Predicting individual ECT responses using neuroimaging data is promising but faces methodological and practical limitations. Machine learning techniques applied to structural MRI data in this study achieved a 69% accuracy in predicting ECT responses, suggesting potential for overcoming current limitations in translating treatment biomarkers into clinical practice.

EXPERIMENTAL NEUROLOGY (2021)

Article Multidisciplinary Sciences

Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study

Wei Zheng et al.

Summary: Based on the study of 30 patients with treatment-refractory depression, it was found that serum BDNF levels do not seem to be a reliable biomarker to determine the antidepressant effects of ketamine as an anaesthesia in ECT. Further studies with larger sample sizes are needed to confirm these findings.

PEERJ (2021)

Article Neurosciences

Frontotemporal Transcranial Direct Current Stimulation Decreases Serum Mature Brain-Derived Neurotrophic Factor in Schizophrenia

Ondine Adam et al.

Summary: The study investigated the acute effects of tDCS on serum mature BDNF levels in schizophrenia patients and found that active tDCS resulted in a significantly larger decrease in mature BDNF levels compared to sham tDCS. This suggests that mature BDNF may play a role in the beneficial effects of frontotemporal tDCS observed in patients with schizophrenia.

BRAIN SCIENCES (2021)

Article Clinical Neurology

A symptom-based approach in predicting ECT outcome in depressed patients employing MADRS single items

Luisa Carstens et al.

Summary: This study found that single item scores from the MADRS were strong predictors of ECT outcomes, particularly affecting symptoms. A stronger reduction in affective symptoms during ECT was positively associated with better treatment outcomes. These findings support the benefits of a symptom-based approach in depression research and treatment.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)

Review Psychiatry

Using EEG to Predict Clinical Response to Electroconvulsive Therapy in Patients With Major Depression: A Comprehensive Review

Louis Simon et al.

Summary: This study aimed to investigate the predictive value of baseline EEG settings on future clinical response to ECT in patients with depressive disorder. Results showed a correlation between P300 amplitude, coherence, and connectivity measures with remission, while sleep EEG recordings did not seem to be correlated with remission after ECT. Further large-scale prospective studies are needed to identify optimal EEG parameters associated with clinical response to ECT in depressive disorder.

FRONTIERS IN PSYCHIATRY (2021)

Article Clinical Neurology

BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy

Karen M. Ryan et al.

BRAIN STIMULATION (2018)

Article Biochemistry & Molecular Biology

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

Ronald S. Duman et al.

NATURE MEDICINE (2016)

Review Neurosciences

BDNF-induced local protein synthesis and synaptic plasticity

Graciano Leal et al.

NEUROPHARMACOLOGY (2014)

Article Biochemistry & Molecular Biology

Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression

J-P Guilloux et al.

MOLECULAR PSYCHIATRY (2012)

Review Medicine, General & Internal

Treatment-resistant depression: therapeutic trends, challenges, and future directions

Khalid Saad Al-Harbi

PATIENT PREFERENCE AND ADHERENCE (2012)

Review Clinical Neurology

The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: A pilot study

Andre Tadic et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)

Review Clinical Neurology

Serum BDNF levels before treatment predict SSRI response in depression

Owen M. Wolkowitz et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)

Article Psychiatry

Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial

Charles H. Kellner et al.

BRITISH JOURNAL OF PSYCHIATRY (2010)

Review Clinical Neurology

Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions

Kenji Hashimoto

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)

Article Clinical Neurology

Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy

Armando Piccinni et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)

Review Neurosciences

Mechanisms, locations, and kinetics of synaptic BDNF secretion: An update

Volkmar Lessmann et al.

NEUROSCIENCE RESEARCH (2009)

Article Multidisciplinary Sciences

Control of extracellular cleavage of ProBDNF by high frequency neuronal activity

Guhan Nagappan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Neurosciences

The yin and yang of neurotrophin action

B Lu et al.

NATURE REVIEWS NEUROSCIENCE (2005)

Article Neurosciences

Effectiveness of electroconvulsive therapy in community settings

J Prudic et al.

BIOLOGICAL PSYCHIATRY (2004)

Article Clinical Neurology

Defining remission by cut off score on the MADRS: selecting the optimal value

CJ Hawley et al.

JOURNAL OF AFFECTIVE DISORDERS (2002)